NCT06608979 Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
| NCT ID | NCT06608979 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Clemson University |
| Condition | Substance Use Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-06-11 |
| Primary Completion | 2025-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-06-11 with a primary completion date of 2025-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this project is to implement a pilot study to investigate the feasibility and preliminary efficacy of a peer support specialist delivered violence prevention program for women in substance use treatment. The program entails a posttraumatic stress disorder (PTSD) screening, resource referral, and two session interpersonal violence prevention protocol for 60 participants. In this single arm trial, women are recruited from three substance use treatment facilities. Participants complete baseline, post-intervention, one-month, and three-month follow-up assessments. Self-report surveys assess trauma exposure, knowledge and behaviors related to interpersonal violence, and intervention engagement.
Eligibility Criteria
Inclusion Criteria: 1\) Age 18 or higher;2) female gender identity; 3) currently engaged in substance use treatment or care (behavioral, peer support, pharmacological, medical) \- Exclusion Criteria: 1\) Non-English-speaking; 2) acute physical and medical conditions that interfere with participation in educational sessions (e.g., active psychosis, suicidality). \-
Contact & Investigator
Heidi Zinzow, Ph.D.
PRINCIPAL INVESTIGATOR
Clemson University
Frequently Asked Questions
Who can join the NCT06608979 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Substance Use Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06608979 currently recruiting?
Yes, NCT06608979 is actively recruiting participants. Contact the research team at hzinzow@clemson.edu for enrollment information.
Where is the NCT06608979 trial being conducted?
This trial is being conducted at Greenville, United States, Greenville, United States.
Who is sponsoring the NCT06608979 clinical trial?
NCT06608979 is sponsored by Clemson University. The principal investigator is Heidi Zinzow, Ph.D. at Clemson University. The trial plans to enroll 60 participants.